Jefferies & Co Initiates Coverage on ResMed (RMD)
More News related to RMD
- ResMed Inc. to Present at Upcoming Conferences in June
- ResMed (RMD) Reports Q1 EPS of $0.52, Beats by 6c
- ResMed Inc. Announces Record Financial Results for the Quarter and Nine Months Ended March 31, 2009
- ResMed Inc. to Present at Upcoming Healthcare Conferences in May
- Wachovia Downgrades ResMed (RMD) to Market Perform
Jefferies & Co initiates coverage on ResMed (NYSE: RMD) with a Buy.
ResMed Inc. is a developer, manufacturer and distributor of medical equipment for treating, diagnosing, and managing sleep-disordered breathing (SDB) and other respiratory disorders.
Related Categories
New CoverageStocks Mentioned
-15.28Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
